Front Row lecture series
Learn from the world’s leading scientists
Latest lecture:
Accelerating evolution to create new medicines
Biologic drugs account for about a quarter of recent drug approvals, and most are antibodies. Although antibodies have transformed treatment for many conditions, they mainly work by binding to their targets. But some diseases may benefit more from therapeutics that can selectively alter those targets instead. In this free Front Row lecture, Assistant Professor Christian Diercks discussed how he harnesses accelerated evolution—a laboratory process that speeds up cycles of genetic change and selection—to engineer therapeutic enzymes that actively break down or modify disease-related molecules. At the center of this work is T7-ORACLE, a synthetic biology platform developed by Diercks’ lab. It continuously introduces mutations into selected genes in bacteria to rapidly evolve proteins, including enzymes, at large scale with minimal researcher intervention. The Diercks lab is using T7-ORACLE to evolve enzymes for the selective degradation of the painful crystals behind gout flares, and to target voltage-gated ion channels involved in chronic pain as a non-addictive alternative to opioid-based therapeutics.
Presentation slides
Key takeaways
Enjoy previous lectures at any time…from the comfort of your home.
Our Front Row Lecture Series encompasses the depth and breadth of modern science. Take a journey inside the human brain to learn how reactions to emotions can shape behavior. Circle the globe to discover how Scripps Research scientists are helping countries outsmart outbreaks. And get a first-hand look at the future of personalized medicine. Whatever your interest, you’ll find a Front Row lecture to enjoy.
Season 9 Season 8 Season 7: Centennial Celebration Season 6 Season 5 Season 4 Season 3 Season 2 Season 1